Pharmafile Logo
Pharmafocus logo
Advanced Search

immunology

Showing 15 posts of 18 posts found.

AbbVie and Tentarix collaborate on oncology and immunology treatments

February 23, 2024
Research and Development AbbVie, Oncology, collaboration, immunology

AbbVie and Tentarix Biotherapeutics have announced that they have entered a multi-year collaboration focused on the discovery and development of …

News

Gilead and Compugen enter exclusive license agreement for immunotherapy programme

December 20, 2023
Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology

Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …

News

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023
Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …

News
towfiqu-barbhuiya-ssz6x-gao0c-unsplash

Sosei Heptares and Cancer Research UK announce first patient dosed in phase 1/2a trial

August 10, 2023
Research and Development Cancer Research UK, Oncology, Sosei Heptares, clinical trial, immunology

Sosei Heptares and Cancer Research UK have announced that the first patient has been dosed in their phase 1/2a clinical …

News

Eli Lilly to acquire DICE Therapeutics for immunology innovations

June 21, 2023
Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology

Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …

News
conference_peach

The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns

March 10, 2020
Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology

The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …

News
sobi_offices

Sobi acquire Novimmune in deal worth more than £400 million

June 13, 2019
Business Services, Research and Development R&D, emapalumab, immuno-oncology, immunology, pharma

Swedish rare disease specialist Sobi has agreed to buy Swiss firm Novimmune ion a deal worth more than £400 million. …

News
amgen_flag

Amgen agrees to buy Nuevolution for $167 million

May 22, 2019
Research and Development Amgen, Cancer, Nuevolution, biotech, drug discovery, immuno-oncology, immunology, pharma

California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million). The …

News

Doctors cure ‘bubble boy syndrome’ using modified version of HIV

April 18, 2019
Research and Development HIV, SCID-X1, gene therapy, immunodeficiency, immunology

Doctors at St. Jude Children’s Research Hospital have been able to treat patients with X-linked severe combined immunodeficiency (SCID-X1) – …

News

J&J sign deal with Scottish firm AdoRx to develop novel lung cancer treatments

March 1, 2019
Medical Communications AdoRx, Cancer, Cancer Immunotherapy, J&J, JJ, immunology, oncology

Edinburgh-based drug discovery firm AdoRx therapeutics has signed a deal with US healthcare conglomerate Johnson & Johnson to develop novel …

News

Smoking may limit immune system’s ability to fight cancer, study shows

February 18, 2019
Sales and Marketing Cancer, cancer research, immune system, immunology, melanoma, oncology, smoking

Smoking may limit the body’s ability to fight melanoma, according to a study published in the journal Cancer Research. The …

News
pharmafile_autumn_2018

The Autumn 2018 edition of Pharmafile is available to read online now!

December 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

News
800px-t_lymphocyte_16760076824

Antibody therapy supresses HIV for months after treatment, study shows

October 1, 2018
Sales and Marketing HIV, immunology, immunotherapy, nature, research

Researchers from the New York City based Rockefeller University have developed a novel immunotherapy, which is capable of suppressing HIV …

News

Roche acquires immuno-oncology biotech Tusk in €655m deal

October 1, 2018
Sales and Marketing Droia, Roche, Tusk, immuno-oncology, immunology, oncology

Swiss multinational Roche has acquired the privately held immuno-oncology company Tusk Therapeutics in a deal that could be worth up …

News
chugai_pharmaceutical

Chugai partners with Osaka University in £62 million immunology collaboration

May 20, 2016
Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university

Chugai Pharmaceuticals (TOKYO: 4519) has announced a collaboration agreement with Osaka University in advanced immunology research worth up to £62 …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024